Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998.
paper
Cited
Public
Unavailable
- Authors
- Burton, S L; Gitchell, J G; Shiffman, S; Centers for Disease Control and Prevention (CDC)
- Year
- 2000
- Journal
- MMWR. Morbidity and mortality weekly report
- PMID
- 10943254
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| An exploratory, randomised, crossover study to investigate the effect of nicotine on cognitive function in healthy adult smokers who use an electronic cigarette after a period of smoking abstinence. | Green HJ et al. | — | 2024 | → |
| Trends in Over-the-Counter Nicotine Replacement Therapy Sales, U.S., 2017‒2020. | Trigger S et al. | — | 2023 | → |
| Use of Vaping as a Smoking Cessation Aid: A Review of Clinical Trials. | Ashour AM | — | 2023 | → |
| Examining sex differences in pleiotropic effects for depression and smoking using polygenic and gene-region aggregation techniques. | Schmitz LL et al. | — | 2019 | → |
| Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". | Apollonio D et al. | — | 2017 | → |
| Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco. | Fucito LM et al. | — | 2014 | → |
| Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers. | Martin CA et al. | — | 2014 | → |
| Developing a Rational Approach to Tobacco Use Treatment in Pulmonary Practice: A Review of the Biological Basis of Nicotine Addiction. | Leone FT et al. | — | 2012 | → |
| Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. | Chen LS et al. | — | 2012 | → |
| Effects of transdermal nicotine and concurrent smoking on cognitive performance in tobacco-abstinent smokers. | Kleykamp BA et al. | — | 2011 | → |
| The multiphase optimization strategy for engineering effective tobacco use interventions. | Collins LM et al. | — | 2011 | → |
| Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey. | Fix BV et al. | — | 2011 | → |
| Increasing access to evidence-based smoking cessation treatment: effectiveness of a free nicotine patch program among Chinese immigrants. | Shelley D et al. | — | 2010 | → |
| Adverse effects with use of nicotine replacement therapy among quitline clients. | Ossip DJ et al. | — | 2009 | → |
| A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. | Piper ME et al. | — | 2009 | → |
| Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. | Smith SS et al. | — | 2009 | → |
| Presence of the carcinogen N'-nitrosonornicotine in the urine of some users of oral nicotine replacement therapy products. | Stepanov I et al. | — | 2009 | → |
| Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics. | Shiffman S et al. | — | 2008 | → |
| Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced? | Amodei N et al. | — | 2008 | → |
| Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey. | Hammond D et al. | — | 2008 | → |
| Smoking cessation in primary care. | David SP et al. | — | 2008 | → |
| Use of nicotine replacement therapy among never smokers in the 1999-2006 National Health and Nutrition Examination Surveys. | Gerlach KK et al. | — | 2008 | → |
| Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. | Aubin HJ et al. | — | 2008 | → |
| Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell). | Dautzenberg B et al. | — | 2007 | → |
| The treatment of smoking by US physicians during ambulatory visits: 1994 2003. | Thorndike AN et al. | — | 2007 | → |
| Use of more nicotine lozenges leads to better success in quitting smoking. | Shiffman S | — | 2007 | → |
| Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. | Weaver MF et al. | — | 2006 | → |
| Current and emerging pharmacotherapies for treating tobacco dependence. | Schnoll RA et al. | — | 2006 | → |
| Characteristics of selectors of nicotine replacement therapy. | Shiffman S et al. | — | 2005 | → |
| Combination treatment for nicotine dependence: state of the science. | Ingersoll KS et al. | — | 2005 | → |
| Impact of UK policy initiatives on use of medicines to aid smoking cessation. | West R et al. | — | 2005 | → |
| Over-the-counter availability of nicotine replacement therapy and smoking cessation. | Hyland A et al. | — | 2005 | → |
| Tobacco control competencies for US medical students. | Geller AC et al. | — | 2005 | → |
| Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. | Cokkinides VE et al. | — | 2005 | → |
| Advances in pharmacotherapy for tobacco dependence. | Foulds J et al. | — | 2004 | → |
| Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy. | Shiffman S et al. | — | 2004 | → |
| Impact of economic policies on reducing tobacco use among Medicaid clients in New York. | Murphy JM et al. | — | 2003 | → |
| Impact of patient characteristics on physician's smoking cessation strategies. | Ellerbeck EF et al. | — | 2003 | → |
| Nicotine gum-induced atrial fibrillation. | Choragudi NL et al. | — | 2003 | → |
| The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy. | Hudmon KS et al. | — | 2003 | → |
| Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. | Thorndike AN et al. | — | 2002 | → |
| Examining the effects of tobacco treatment policies on smoking rates and smoking related deaths using the SimSmoke computer simulation model. | Levy DT et al. | — | 2002 | → |
| Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. | Tran MT et al. | — | 2002 | → |
| Risk of acute first myocardial infarction and use of nicotine patches in a general population. | Kimmel SE et al. | — | 2001 | → |